首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   531443篇
  免费   48457篇
  国内免费   1815篇
耳鼻咽喉   8545篇
儿科学   16803篇
妇产科学   12392篇
基础医学   65737篇
口腔科学   17098篇
临床医学   59242篇
内科学   115428篇
皮肤病学   15319篇
神经病学   51971篇
特种医学   17927篇
外国民族医学   129篇
外科学   76121篇
综合类   2096篇
现状与发展   40篇
一般理论   114篇
预防医学   47613篇
眼科学   10755篇
药学   31063篇
中国医学   1168篇
肿瘤学   32154篇
  2023年   7001篇
  2022年   3572篇
  2021年   9233篇
  2020年   9120篇
  2019年   8962篇
  2018年   18219篇
  2017年   15124篇
  2016年   16426篇
  2015年   16801篇
  2014年   20669篇
  2013年   28722篇
  2012年   29635篇
  2011年   30408篇
  2010年   21028篇
  2009年   20354篇
  2008年   27491篇
  2007年   27972篇
  2006年   27710篇
  2005年   26345篇
  2004年   24042篇
  2003年   22679篇
  2002年   21746篇
  2001年   15313篇
  2000年   15936篇
  1999年   12882篇
  1998年   5363篇
  1997年   4576篇
  1996年   4229篇
  1995年   3701篇
  1994年   2895篇
  1993年   2561篇
  1992年   5976篇
  1991年   5402篇
  1990年   5078篇
  1989年   4738篇
  1988年   4396篇
  1987年   4201篇
  1986年   3876篇
  1985年   3720篇
  1984年   2968篇
  1983年   2559篇
  1982年   1793篇
  1979年   2304篇
  1978年   1794篇
  1977年   1683篇
  1975年   1665篇
  1974年   1886篇
  1973年   1786篇
  1972年   1670篇
  1971年   1646篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.

Background

Limited data exists demonstrating the efficacy of minimally invasive surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease (MVD). This systematic review and meta-analysis aims to compare operative and peri-operative outcomes of MIS vs MS in MVD.

Methods

PubMed, Ovid, and Embase were searched from inception until August 2019 for randomized and observational studies comparing MIS and MS in patients with MVD. Clinical outcomes of intra- and postoperative times, reoperation for bleeding and surgical site infection were evaluated.

Results

Five observational studies comparing 340 MIS vs 414 MS patients were eligible for qualitative and quantitative review. The quality of evidence assessed using the Newcastle-Ottawa scale was good for all included studies. Meta-analysis demonstrated increased cardiopulmonary bypass time for MIS patients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI], 0.365-0.608; P < .0001). Similarly, aortic cross-clamp time was longer in patients undergoing MIS (WMD, 0.632; 95% CI, 0.509-0.755; P < .0001). No differences were found in operative mortality, reoperation for bleeding, surgical site infection, or hospital stay.

Conclusions

MIS for MVD have similar short-term outcomes compared to MS. This adds value to the use of minimally invasive methods for multivalvular surgery, despite conferring longer operative times. However, the paucity in literature and learning curve associated with MIS warrants further evidence, ideally randomized control trials, to support these findings.
  相似文献   
5.

Background

Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.

Materials and methods

Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.

Results

EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.

Conclusion

This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.  相似文献   
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号